While there are general exercise and nutrition guidelines for everyone, your genetics will determine how much you need to ...

Research from Karolinska Institutet shows that long-term sex hormone treatment in transgender individuals can lead to ...

New research from Karolinska Institutet shows that long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular ...

A growing body of research continues to find that the gut microbiome and the immune system work together to maintain the ...

Fibrodysplasia ossificans progressiva (FOP), also known as "stone man disease" or "Münchmeyer disease"Affected populations: ...

Analysts at Royal Bank of Canada assumed coverage on shares of Dyne Therapeutics (NASDAQ:DYN – Get Free Report) in a report ...

New research shows that long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular disease, particularly in ...

New research from Karolinska Institutet shows that long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular ...

For healthy aging, it’s crucial to distinguish between lifespan and healthspan: the amount of time for which a person is ...

Sarepta will pay Arrowhead Pharmaceuticals $500 million upfront, make a $325 million equity investment, plus pay $250 million over five years, and more.

Morgan Stanley analyst Michael Ulz maintained a Hold rating on Arrowhead Pharmaceuticals (ARWR – Research Report) today and set a price target ...

Keros Therapeutics, Inc. has recently announced its participation in two upcoming healthcare conferences. The company's Chair ...